$5.95
-0.02-0.34%
Pre-Market: 7:09 AM EDT
15 minutes delayed
Capricor Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Capricor Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.35 | $-0.36 | 2.78 % |
Mar 2024 | 2024-05-13 | $-0.31 | $-0.11 | -181.8 % |
Dec 2023 | 2024-02-29 | $-0.02 | $-0.09 | 77.8 % |
Sep 2023 | 2023-11-14 | $-0.25 | $-0.29 | 13.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $3.97M | $3.66M | 8.50 % |
Mar 2024 | 2024-05-13 | $4.91M | $9.70M | -49.4 % |
Dec 2023 | 2024-02-29 | $12.09M | $10.60M | 14.0 % |
Sep 2023 | 2023-11-14 | $6.19M | $2.11M | 193.1 % |
Capricor Therapeutics (CAPR) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.35, which beat the estimate of $-0.36.
The Actual Revenue was $4M, which beat the estimate of $3.7M.
Browse earnings estimates, EPS, and revenue on all stocks.